Alcohol use in opioid agonist treatment
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Alcohol misuse among individuals receiving agonist treatment for an opioid use disorder is common and is associated with significant morbidity and mortality. At present, though substantial research highlights effective strategies for the screening, diagnosis and management of an alcohol or opioid use disorder individually, less is known about how best to care for those with a dual diagnosis especially since common treatments for opioid addiction may be contraindicated in a setting of alcohol use. This review summarizes existing research and characterizes the prevalence, clinical implications and management of alcohol misuse among individuals with opioid addiction. Furthermore, it highlights clinically relevant management strategies in need of future research to advance care for this unique, but important, patient population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krupitsky, E., Nunes, E. V., Ling, W., Illeperuma, A., Gastfriend, D. R., & Silverman, B. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60358-9 · Cited by 555
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01523.x · Cited by 366
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347 · cited 1×
“While two subsequent meta-analyses [71, 72] did demonstrate efficacy with the use of disulfiram when administered in a supervised setting among individuals with alcohol abuse or dependence regarding short term abstinence, days until relapse and number of drinking days, it should be noted that receipt of methadone was…”
ResultAn analysis of the root causes for opioid-related overdose deaths in the United States
Webster, L. R., Cochella, S., Dasgupta, N., Fakata, K. L., Fine, P. G., Fishman, S. M., Grey, T., Johnson, E. M., Lee, L. K., Passik, S. D., et al. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01134.x · Cited by 295 · cited 1×
“In addition, during methadone initiation, a period already known to be associated with an increased risk for overdose and mortality [34, 36], concurrent acute ethanol consumption can further compound this risk by increasing CNS and/or respiratory depression [37, 38].”
BackgroundScreening and Brief Intervention for Drug Use in Primary Care: The ASPIRE Randomized Clinical Trial
Saitz, R., Palfai, T. P. A., Cheng, D. M., Alford, D. P., Bernstein, J. A., Lloyd-Travaglini, C. A., Meli, S. M., Chaisson, C. E., & Samet, J. H. (2014) · JAMA · doi:10.1001/jama.2014.7862 · Cited by 280
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal
Myrick, H., Malcolm, R., Randall, P. K., Boyle, E., Anton, R. F., Becker, H. C., & Randall, C. L. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00986.x · Cited by 201
Roy-Byrne, P., Bumgardner, K., Krupski, A., Dunn, C., Ries, R., Donovan, D., West, I. I., Maynard, C., Atkins, D. C., Graves, M. C., et al. (2014) · JAMA · doi:10.1001/jama.2014.7860 · Cited by 188
Williams, E. C., Johnson, M. L., Lapham, G. T., Caldeiro, R. M., Chew, L., Fletcher, G. S., McCormick, K. A., Weppner, W. G., & Bradley, K. A. (2011) · Psychology of Addictive Behaviors · doi:10.1037/a0022102 · Cited by 138 · cited 1×
“Despite this finding, implementation of these interventions among primary care providers of OAT has been slow [55] and remains variable with rates ranging between 2 and 93% [56, 57].”
BackgroundAlcohol Use Disorders in Opioid Maintenance Therapy: Prevalence, Clinical Correlates and Treatment
Soyka, M. (2015) · European Addiction Research · doi:10.1159/000363232 · Cited by 77
Cited by
Witkiewitz, K., & Vowles, K. E. (2018) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13594 · Cited by 248
“Further, use of alcohol may interfere with OUD treatment, particularly medication-assisted treatment (El-Bassel et al., 1993; H€akkinen et al., 2012; Nolan et al., 2016; Senbanjo et al., 2007).”
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus
Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1409722 · Cited by 141
“Chronic alcohol use increases metabolism of methadone [94], and opioid users who are chronically intoxicated with alcohol are difficult to manage [95].”
BackgroundCrotty, K., Freedman, K. I., & Kampman, K. M. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000635 · Cited by 95
Klimas, J., Fairgrieve, C., Tobin, H., Field, C.-A., O'Gorman, C. S., Glynn, L. G., Keenan, E., Saunders, J., Bury, G., Dunne, C., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009269.pub4 · Cited by 40
Self-citation
Metadata
- Authors
- Nolan, S., Klimas, J., & Wood, E.
- Venue
- Addiction Science & Clinical Practice
- Published
- 2016-12
- Volume
- 11
- Issue
- 1
- Pages
- 17-17
- ISSN
- 1940-0632 (ISSN-L)
- 1940-0640
- OpenAlex
- W2560157258
- Cited by
- 47
- References
- 9
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alcohol use in opioid agonist treatment. https://app.cochat.ai/papers/10.1186/s13722-016-0065-6
- The paper
- Nolan, S., Klimas, J., & Wood, E. (2016). Alcohol use in opioid agonist treatment. Addiction Science & Clinical Practice. https://doi.org/10.1186/s13722-016-0065-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.